$IRWD News Article - Ironwood Pharmaceuticals and Allergan Initiate Patient Dosing in Phase II Clinical Trial of MD-7246 in Patients with Abdominal Pain Associated with IBS-D https://marketwirenews.com/news-releases/iron...89332.html
(0)
(0)
Ironwood Pharmaceuticals (IRWD) Stock Research Links